ArticleOncoimmunology2021

Addition of camrelizumab to docetaxel, cisplatin, and radiation therapy in patients with locally advanced esophageal squamous cell carcinoma: a phase 1b study.

Wencheng Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.